CRISPR THERAPEUTICS AG (CRSP) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

Pattern note: compression remains elevated around 11%, which means breakout quality matters more than noise inside the pattern.

📊 Technical Summary

CRISPR THERAPEUTICS AG (CRSP) closed at 52.34 (+3.21%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is positive at +7.23%, with price remains inside its roughly 52-week range (33.16–76.78), while ATR14 volatility is elevated at roughly 5.98% of price. RSI(14) is 49.6, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. Nearby upside pressure sits around 52.51. A decisive move through that level would improve the short-term picture. Latest fundamentals snapshot: Revenue: 889,000 · Net income: -581.60M · EPS (basic): -1.17. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more